News Headlines Article

Stanford, UCSF target better drug development in new FDA partnership
San Francisco Business Times

Stanford University and UCSF will work together in a first-on-the-West-Coast center aimed at streamlining drug development and regulatory approval, the institutions said Monday. The center, backed by an initial $3.3 million grant from the Food and Drug Administration, will work on three central areas: boosting preclinical safety and efficacy tests, improving clinical trials and evaluation, and pulling together various data sets to speed and better focus new drug development.